Tirzepatide (marketed as Mounjaro) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for type 2 diabetes management and weight loss
Looking at a separate study of people with both obesity and type 2 diabetes, weight loss was understandably slightly lower diabetes medications and metabolic differences often blunt the response but still substantial
Semaglutide stays in your system for several weeks due to its long half-life, so the medication continues to work even if a dose is slightly delayed
Ozempic is the brand name for a medication called semaglutide and is part of a broad class of drugs known as GLP-1 agonists
Statistics Statistical analyses were performed using GraphPad Prism (version 10.4.1, GraphPad Software Inc., Boston, MA, USA)
Strictly for research purposes only